CM
IOVA icon

Caption Management’s Iovance Biotherapeutics IOVA Stock Holding History

Caption Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,000
Closed -$281K – 1443
2024
Q2 		$281K Sell
35,000
-15,000
-30% -$161K ﹤0.01% 909
2024
Q1 		$741K Sell
50,000
-1,779,500
-97% -$20.7M 0.01% 805
2023
Q4 		$14.9M Buy
1,829,500
+955,200
+109% +$5M 0.2% 125
2023
Q3 		$3.98M Buy
874,300
+844,300
+2,814% +$5.51M 0.06% 382
2023
Q2 		$211K Hold
30,000
– – ﹤0.01% 932
2023
Q1 		$183K Buy
+30,000
New +$207K ﹤0.01% 927
2022
Q4 		– Sell
-90,000
Closed -$862K – 1482
2022
Q3 		$862K Sell
90,000
-282,100
-76% -$3.25M 0.01% 909
2022
Q2 		$4.11M Buy
372,100
+322,100
+644% +$4.22M 0.06% 419
2022
Q1 		$833K Sell
50,000
-928,200
-95% -$14.4M 0.01% 1029
2021
Q4 		$18.7M Buy
978,200
+948,200
+3,161% +$20.9M 0.21% 108
2021
Q3 		$740K Buy
+30,000
New +$707K 0.01% 1115
2021
Q2 		– Sell
-229,200
Closed -$7.26M – 1427
2021
Q1 		$7.26M Sell
229,200
-19,800
-8% -$821K 0.16% 166
2020
Q4 		$11.6M Buy
249,000
+199,000
+398% +$7.9M 0.26% 98
2020
Q3 		$1.65M Sell
50,000
-230,600
-82% -$7.07M 0.04% 497
2020
Q2 		$7.7M Buy
+280,600
New +$9.22M 0.26% 99
2020
Q1 		– Sell
-156,300
Closed -$4.33M – 961
2019
Q4 		$4.33M Sell
156,300
-166,900
-52% -$3.8M 0.15% 192
2019
Q3 		$5.88M Buy
323,200
+293,200
+977% +$6.48M 0.31% 90
2019
Q2 		$735K Buy
+30,000
New +$452K 0.04% 425

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Caption Management's IOVA Position: Q1 2025 in Review

Caption Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 38,500 shares — an estimated $285K sold.

Caption Management first reported a position in IOVA in Q2 2019 and held it in 15 quarters. The position peaked at $4.35M in Q1 2020. 301 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

  • Caption Management reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Caption Management sold 38,500 Iovance Biotherapeutics shares in Q1 2025, an estimated $285K.
  • Caption Management first reported a position in Iovance Biotherapeutics in Q2 2019 and held it in 15 quarters.
  • Caption Management's Iovance Biotherapeutics position peaked at $4.35M in Q1 2020.
  • 301 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.